iFabric Launches Scrubs Program at Major US Retailer
Rhea-AI Summary
iFabric (OTCQX:IFABF) announced that its subsidiary Intelligent Fabric Technologies (North America) Inc. has begun the launch of Doctor's Choice Next Generation scrubs with an initial rollout at a leading U.S. national big-box retailer. The first collections integrate IFTNA flagship technologies: PROTX2 (advanced antimicrobial), ecoPEL (C0 PFC-free DWR), and DryTX (moisture management).
Collections will launch online first, with in-store availability expected at the end of October 2025. Product claims include clinically proven antimicrobial finish, PFC-free water repellency, and wicking/quick-dry performance designed for clinical use.
Positive
- Initial rollout at a leading U.S. national big-box retailer
- Collections combine PROTX2, ecoPEL, and DryTX technologies
- In-store availability scheduled for end of October 2025
Negative
- None.
MARKHAM, ON, ON / ACCESS Newswire / October 15, 2025 / iFabric Corp. ("iFabric" or the "Company") (TSX:IFA)(OTCQX:IFABF) announces that its wholly owned subsidiary, Intelligent Fabric Technologies (North America) Inc. ("IFTNA"), has begun the launch of Doctor's Choice® Next Generation scrubs with an initial rollout at a leading U.S. national big-box retailer.
The first collections will integrate three of IFTNA's flagship textile technologies, combining PROTX2® (advanced antimicrobial) with ecoPEL® (C0 PFC-free durable water repellent), and PROTX2® (advanced antimicrobial) with DryTX™ (moisture-management); delivering two performance scrub platforms designed for everyday clinical demands. These fabric treatments are targeted to provide scrubs that are cleaner, safer, and more comfortable, with these benefits expected to last through the life of the scrubs. The first collections will initially launch online, with instore availability at the end of October 2025. The following is a link to one of the items in the range:
"Doctor's Choice Next Generation scrubs are built to give healthcare professionals reliable, lab-tested performance where it matters most," said Giancarlo Beevis, President & CEO of IFTNA. "By combining PROTX2 with ecoPEL, and PROTX2 with DryTX, we're helping set a new benchmark for comfort, protection, and durability in medical apparel," concluded Mr. Beevis.
Collection Highlights
PROTX2® Antimicrobial: Clinically proven anti-microbial performance finish.
ecoPEL® DWR: C0, PFC-free water repellency to help resist fluid penetration while supporting environmental sustainability goals.
DryTX™ Moisture Management: Wicking and quick-dry properties to enhance all-shift comfort and breathability.
Designed for Care: Soft-hand feel, stretch options, and utility pocketing; styles and fits tailored for clinical workflow.
The launch underscores IFTNA's strategy to broaden adoption of it's technologies across high-use uniform categories, pairing evidence-driven finishes with mass-market accessibility through the retailer's nationwide footprint.
About iFabric Corp.
iFabric Corp. (TSX:IFA)(OTCQX:IFABF) develops, licenses, and commercializes innovative performance technologies for textiles and apparel. Through its Intelligent Fabric Technologies (North America) division, iFabric partners with global brands and retailers to deliver enhanced functionality-ranging from antimicrobial and moisture management to PFAS-free water repellency-across diverse end uses. For more information, visit www.ifabriccorp.com.
About IFTNA
Intelligent Fabric Technologies (North America) Inc., a wholly owned subsidiary of iFabric Corp., engineers and supplies proprietary chemistries-including PROTX2®, ecoPEL®, and DryTX™ to elevate textile performance in consumer, medical, and industrial markets.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of applicable securities laws, including statements regarding the referenced products, product launches, market adoption, and anticipated performance features. Forward-looking statements are based on current expectations and involve risks and uncertainties that could cause actual results to differ materially. iFabric undertakes no obligation to update forward-looking statements except as required by law.
FOR FURTHER INFORMATION PLEASE CONTACT:
Hylton Karon, President & CEO | Giancarlo Beevis, COO | Hilton Price, CFO |
Website: www.ifabriccorp.com
Neither the TSX Exchange nor its Regulations Services Provider (as that term is defined in the policies of the TSX Exchange) accepts responsibility for the adequacy or accuracy of this press release.
SOURCE: iFabric Corp
View the original press release on ACCESS Newswire
FAQ
When will iFabric (IFABF) Doctor's Choice Next Generation scrubs be available in stores?
What technologies are included in iFabric (IFABF) Doctor's Choice Next Generation scrubs?
Which retailer is carrying iFabric (IFABF) Doctor's Choice scrubs online at launch?
What performance benefits does iFabric (IFABF) claim for the new scrub collections?
Who is leading the rollout of the Doctor's Choice Next Generation scrubs for iFabric (IFABF)?
